Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34118197

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2021 Jul
First author
Gainor JF

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Aug;22(8):e347. doi: 10.1016/S1470-2045(21)00392-2.
    note
    Source null
    related pmid
    34339651
    relationship
    Erratum in
  2. citation
    Am J Respir Crit Care Med. 2024 Mar 15;209(6):748-750. doi: 10.1164/rccm.202208-1596RR.
    note
    Source null
    related pmid
    38190703
    relationship
    Comment in

Authors and identifiers

  1. name
    Gainor JF
    type
    Author
  2. name
    Curigliano G
    type
    Author
  3. name
    Kim DW
    type
    Author
  4. name
    Lee DH
    type
    Author
  5. name
    Besse B
    type
    Author
  6. name
    Baik CS
    type
    Author
  7. name
    Doebele RC
    type
    Author
  8. name
    Cassier PA
    type
    Author
  9. name
    Lopes G
    type
    Author
  10. name
    Tan DSW
    type
    Author
  11. name
    Garralda E
    type
    Author
  12. name
    Paz-Ares LG
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Gainor JF
    type
    Author
  2. name
    Curigliano G
    type
    Author
  3. name
    Kim DW
    type
    Author
  4. name
    Lee DH
    type
    Author
  5. name
    Besse B
    type
    Author
  6. name
    Baik CS
    type
    Author
  7. name
    Doebele RC
    type
    Author
  8. name
    Cassier PA
    type
    Author
  9. name
    Lopes G
    type
    Author
  10. name
    Tan DSW
    type
    Author
  11. name
    Garralda E
    type
    Author
  12. name
    Paz-Ares LG
    type
    Author
bibliography ids
  1. nci-bib-e030fae94f1a18460ee061ab
book metadata
content sha256
36c30dd63a3eeefe6d32b33517026890e43b4b434b57b03af389d704db00cebb
document type
citation
dois
  1. 10.1016/S1470-2045(21)00247-3
electronic publication date
display
2021 Jun 9
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34118197
immutable id
pubmed:34118197@36c30dd63a3eeefe6d32b33517026890e43b4b434b57b03af389d704db00cebb
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
7
name
The Lancet. Oncology
nlm unique id
100957246
pages
959-969
volume
22
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Aug;22(8):e347. doi: 10.1016/S1470-2045(21)00392-2.
    note
    Source null
    related pmid
    34339651
    relationship
    Erratum in
  2. citation
    Am J Respir Crit Care Med. 2024 Mar 15;209(6):748-750. doi: 10.1164/rccm.202208-1596RR.
    note
    Source null
    related pmid
    38190703
    relationship
    Comment in
outcomes validated
false
pmid
34118197
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
854c0b6d89a34eb0cec4a9b2506a2433536bd4c237282bc308c38f074df68893
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Jul
precision
month
year
2021
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34118197/
title
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.

Preserved source evidence · Not medical advice